Press Releases

January 17, 2019

ProMIS Neurosciences to Participate in NobleCon15 and CanTech Investment Conferences

December 18, 2018

ProMIS Neurosciences to Present at Sachs Associates Neuroscience Innovation Forum and China Focus@JPMWeek

December 17, 2018

ProMIS Neurosciences Appoints Renowned Neuroscientist, Dr. Rudolph Tanzi, to Scientific Advisory Board

In the News

December 18, 2018

DDN News – ProMIS tackles Parkinson’s and Alzheimer’s diseases

December 18, 2018

The Canadian Business Quarterly – Targeting the Root Cause of Alzheimer’s and Other Neurodegenerative Diseases

September 12, 2018

Global Business Report – Interview with Eugene Williams Executive Chairman, ProMIS

Presentations

November 20, 2018

Narrated year to date overview Nov 2018 – video

November 6, 2018

The Critical Importance Of Selectivity When Developing Antibody Therapies For Alzheimer’s Disease And Our Current Phase 1 Design Considerations – Presentation

August 7, 2018

AAIC Report 2018 – Narrated Overview

Videos

November 20, 2018

Narrated year to date overview Nov 2018 – video

November 6, 2018

The Critical Importance Of Selectivity When Developing Antibody Therapies For Alzheimer’s Disease And Our Current Phase 1 Design Considerations – Presentation

August 7, 2018

AAIC Report 2018 – Narrated Overview